or Try an Advanced Search...

    Anti Diabetic Drugs Stocks List

    Symbol Grade Name % Change
    NVO C Novo Nordisk A/S 2.17
    TERN F Terns Pharmaceuticals, Inc. -0.52
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Obesity Peptide Hormones Bile Acid Chronic Liver Diseases Diabetes Diabetes Care Endocrine System Glucagon Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Hepatitis Hormone Therapy Hormones Inflammation Insulin Life Sciences Liver

    Related ETFs - A few ETFs which own one or more of the above listed Anti Diabetic Drugs stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 23.21
    PPH C Market Vectors Pharmaceutical ETF 9.76
    IGTR C Innovator Gradient Tactical Rotation Strategy ETF 8.1
    PJIO D PGIM Jennison International Opportunities ETF 7.68
    AADR A WCM BNY Mellon Focused Growth ADR ETF 6.52
    View all Anti Diabetic Drugs ETFs...
    Compare ETFs
    Compare EDEN to AADR Compare EDEN to PPH Compare IGTR to AADR

        Anti Diabetic Drugs Stocks Recent News

        Date Stock Title
        May 7 TERN Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
        May 7 NVO 13 Best Stocks That Will Always Grow
        May 6 NVO Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
        May 6 NVO Investors Pile Into Amgen in Search of Next Obesity Drug Payout
        May 6 NVO Novo Nordisk doses first subject in Phase I trial of NLRP3 inhibitor
        May 6 NVO 'Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity Problem
        May 4 NVO Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
        May 4 NVO Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
        May 3 NVO Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
        May 3 NVO Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
        May 3 NVO Analyst unveils Amgen stock price target after weight-loss drug data
        May 3 NVO The FTC Cracks Down On Novo Nordisk's Ozempic
        May 3 NVO Weight-loss drug competition heats up. Is Wegovy in trouble?
        May 3 NVO Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
        May 3 NVO Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
        May 3 NVO FTC Seeks More Information on $16.5 Billion Novo-Catalent Deal
        May 3 NVO Catalent, Novo Nordisk receive FTC request for more information
        May 3 NVO US FTC seeks more information on Novo Nordisk parent-Catalent deal
        May 3 NVO UPDATE 2-US FTC seeks more information on Novo Nordisk parent-Catalent deal
        May 3 NVO Job Market Cools In April: Payrolls Miss Forecasts, Wages Rise Less Than Expected
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Obesity Peptide Hormones Bile Acid Chronic Liver Diseases Diabetes Diabetes Care Endocrine System Glucagon Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Hepatitis Hormone Therapy Hormones Inflammation Insulin Life Sciences Liver
        Anti Diabetic Drugs

        Anti-diabetic drugs are medications used to treat people with diabetes mellitus. They work by either increasing the amount of insulin produced by the body, or by helping the body use the insulin it produces more effectively. Common types of anti-diabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, meglitinides, and alpha-glucosidase inhibitors.

        Browse All Tags